Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Update

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totalling 1,550,100 shares, an increase of 80.5% from the December 15th total of 858,900 shares. Based on an average trading volume of 900 shares, the short-interest ratio is presently 1,722.3 days.

Ascentage Pharma Group International Stock Performance

OTCMKTS ASPHF opened at $6.45 on Wednesday. The business’s 50 day moving average is $6.45 and its two-hundred day moving average is $4.36. Ascentage Pharma Group International has a 12-month low of $6.45 and a 12-month high of $6.45.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.